The Discounted Cash Flow (DCF) valuation of Intra-Cellular Therapies Inc (ITCI) is (3,140.59) USD. With the latest stock price at 83.88 USD, the upside of Intra-Cellular Therapies Inc based on DCF is -3844.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 7.1% | 6.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (12,923.66) - (1,811.28) | (3,140.59) |
| Upside | -15507.3% - -2259.4% | -3844.1% |